Details of the Drug

General Information of Drug (ID: DMTHZ2V)

• Drug Name: RNS60

Indication

Disease Entry	ICD 11	Status	REF
Amyotrophic lateral sclerosis	8B60.0	Phase 2	[1]
Multiple sclerosis	8A40	Phase 2	[2]

• Cross-matching ID: TTD ID: D8SO5T
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT03456882) The Effect of RNS60 on ALS Biomarkers (RNS60). U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT01714089) Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis. U.S. National Institutes of Health.